Rapamycin and Trenbolone Interaction

Monitor
Mechanism-based 47% confidence

Rapamycin and Trenbolone have an interaction requiring monitoring for interaction with 47% confidence. Both Rapamycin and Trenbolone negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. These compounds primarily affect different organ systems.

Compound Profiles

Rapamycin

mTOR Inhibitor | Longevity & Immunosuppression

Rapamycin exerts its effects by binding to the intracellular protein FKBP12, forming a complex that directly and specifically inhibits mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 is a master nutrient-sensing kinase that integrates signals from growth factors, amino acids, energy status, and stress to regulate cell growth, proliferation, and metabolism.

Half-life: ~62 hours Typical dose: 3-6 mg once weekly (longevity protocol) longevity, immune
mtor immunosuppressiveinsulin disruptinglipid disruptingteratogenic
View full profile

Trenbolone

19-Nor Anabolic-Androgenic Steroid | Potent Recomposition Agent

Trenbolone binds to the androgen receptor with approximately three to five times the affinity of testosterone, making it one of the strongest known AR agonists among anabolic steroids. This exceptional binding affinity drives potent activation of AR-dependent gene transcription, resulting in dramatically enhanced nitrogen retention, protein synthesis, and satellite cell proliferation in skeletal muscle.

Half-life: ~3 days (acetate) Typical dose: 200-400 mg/week anabolic
androgen receptoraromataseigf1ngf androgenicblood pressure raisingcarcinogenic riskcardiotoxic
View full profile

Combined Organ Load

Gonads
moderate
Heart
low
Liver
low

Shared Safety Flags

2x 2 compounds disrupt lipids (Rapamycin, Trenbolone). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Rapamycin, Trenbolone). Monitor accordingly.

Frequently Asked Questions

Can I take Rapamycin with Trenbolone?

Yes, but with caution. Both Rapamycin and Trenbolone negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. Regular monitoring is advised.

Is Rapamycin and Trenbolone safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: lipid disrupting, teratogenic. Monitor accordingly.

What are the interactions between Rapamycin and Trenbolone?

Both Rapamycin and Trenbolone negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Rapamycin and Trenbolone?

Rapamycin has a half-life of ~62 hours and Trenbolone has a half-life of ~3 days (acetate). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Rapamycin vs Trenbolone

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.